PHGE
BiomX Inc

1,425
Mkt Cap
$4.2M
Volume
72,298.00
52W High
$22.06
52W Low
$2.31
PE Ratio
-0.09
PHGE Fundamentals
Price
$2.46
Prev Close
$2.75
Open
$2.64
50D MA
$8.06
Beta
0.65
Avg. Volume
114,410.45
EPS (Annual)
-$28.02
P/B
-0.48
Rev/Employee
$0.00
Loading...
Loading...
BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively. The company was founded in March 2015 and is headquartered in Ness Ziona, Israel.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
57

Frequently Asked Questions

What is Market Cap of BiomX Inc?
What is the 52-week high for BiomX Inc?
What is the 52-week low for BiomX Inc?
What is BiomX Inc stock price today?
What was BiomX Inc stock price yesterday?
What is the PE ratio of BiomX Inc?
What is the Price-to-Book ratio of BiomX Inc?
What is the 50-day moving average of BiomX Inc?
How many employess does BiomX Inc has?

Latest PHGE News

View
No PHGE news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.